Kindstar Globalgene Technology Balance Sheet Health
Financial Health criteria checks 4/6
Kindstar Globalgene Technology has a total shareholder equity of CN¥2.9B and total debt of CN¥316.1M, which brings its debt-to-equity ratio to 10.8%. Its total assets and total liabilities are CN¥3.8B and CN¥912.7M respectively.
Key information
10.8%
Debt to equity ratio
CN¥316.05m
Debt
| Interest coverage ratio | n/a |
| Cash | CN¥1.61b |
| Equity | CN¥2.92b |
| Total liabilities | CN¥912.66m |
| Total assets | CN¥3.83b |
Recent financial health updates
Recent updates
Kindstar Globalgene Technology's (HKG:9960) Shareholders Have More To Worry About Than Only Soft Earnings
Oct 04
Kindstar Globalgene Technology, Inc.'s (HKG:9960) Shares Leap 29% Yet They're Still Not Telling The Full Story
Oct 03We Think That There Are More Issues For Kindstar Globalgene Technology (HKG:9960) Than Just Sluggish Earnings
Apr 03Kindstar Globalgene Technology (HKG:9960) Posted Healthy Earnings But There Are Some Other Factors To Be Aware Of
Aug 22Analysts Just Made A Notable Upgrade To Their Kindstar Globalgene Technology, Inc. (HKG:9960) Forecasts
Aug 18We're Not Very Worried About Kindstar Globalgene Technology's (HKG:9960) Cash Burn Rate
Jul 07Kindstar Global (Beijing) Technology, Inc. (HKG:9960) Consensus Forecasts Have Become A Little Darker Since Its Latest Report
Mar 28Financial Position Analysis
Short Term Liabilities: 9960's short term assets (CN¥2.3B) exceed its short term liabilities (CN¥813.3M).
Long Term Liabilities: 9960's short term assets (CN¥2.3B) exceed its long term liabilities (CN¥99.3M).
Debt to Equity History and Analysis
Debt Level: 9960 has more cash than its total debt.
Reducing Debt: 9960 had negative shareholder equity 5 years ago, but is now positive and has therefore improved.
Debt Coverage: 9960's operating cash flow is negative, therefore debt is not well covered.
Interest Coverage: Insufficient data to determine if 9960's interest payments on its debt are well covered by EBIT.
Balance Sheet
Discover healthy companies
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/31 18:05 |
| End of Day Share Price | 2024/12/31 00:00 |
| Earnings | 2024/06/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Kindstar Globalgene Technology, Inc. is covered by 3 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Yang Huang | Credit Suisse |
| Tianyi Yan | Goldman Sachs |
| Jiaqi Zhu | Zhongtai Securities Co. Ltd. |